At Flagship Pioneering, Aram Adourian, partner, knowledge management, uses his skills to leverage internal and external knowledge and informatics across the breadth of the company’s research activities, as he tells LSIPR.
Since its founding in 2000, Flagship Pioneering has set up and fostered the development of more than 100 scientific ventures, resulting in $20 billion in aggregate value, more than 500 issued patents, and more than 50 clinical trials for novel therapeutic agents.
It’s a business that creates and manages life sciences ventures. Every year, it spins out six to eight new companies from its VentureLabs core (its innovation foundry), all of which have unique needs.
Among its impressive portfolio sits Denali Therapeutics, a biotechnology company focused on neurodegenerative diseases, and genome-editing company Editas Medicine.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
LSIPR 50 2018, Aram Adourian, Flagship Pioneering, Denali Therapeutics, patent, therapeutics